Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
80 participants
OBSERVATIONAL
2009-08-01
2019-06-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Slow-wave Enhancement in Adults Aged 30-49
NCT04611828
Pilot Study Comparing the Effectiveness of Two Different Methods of Acoustic Stimulation
NCT03600194
Enhancement of Sleep With Wearables
NCT03420677
Evaluation of SmartSleep Technology for Improving the Efficiency and Restorative Quality of Sleep in Healthy Adults
NCT03911154
Effect of Auditory Stimulation on Spike Waves in Sleep
NCT02562885
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Several different stimulation modalities will be examined including: auditory (soft tones delivered to the subject through earphones); somatosensory (brief and painless electrical pulses delivered to the median nerve through electrodes placed at the wrist); vestibular (brief and painless electrical pulses delivered through electrodes placed near the mastoids); olfactory (light puffs of air, with or without mild odorants, delivered to the nostril(s) and/or mouth; visual (brief light flashes via strobe light). The amplitude (stimulus intensity) and frequency (number of stimuli per unit time) of stimulation presentation will be systematically varied to identify the ideal parameters for slow wave induction during sleep. For each stimulation modality and each subject, we will determine the range of stimulus intensity from the minimum level sufficient for perceptual response (e.g. - the lowest volume setting for an auditory stimulus that the subject can hear) to a stimulus level that the subject deems comfortable to still allow sleep. This is particularly important, as sleep maintenance during these experiments requires stimulus intensity low enough to avoid awakening the subject. Additionally, based on previous results from our laboratory, the effective range of stimulus intensity will vary substantially between subjects - both the identified range during wakefulness, as well as the range that induces slow waves but avoids waking during the sleep recording. Given this response variability, during the sleep recordings stimulus intensity will be adjusted, starting with the range determined in waking, to find the optimal intensity to inducing sleep slow waves (based on EEG response patterns), and avoiding subject awakening.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
short-sleepers
subset of participants will be recruited who report less than typical work/ weekday sleep in order to examine whether enhancing sleep with stimulation will reduce the amount of extra sleep subjects usually get on the weekends.
Slow-wave optimization
employing sensory stimulation to enhance slow waves
shift-workers
An additional subset of participants will be recruited who work evening shifts to see if enhanced sleep can counteract some of the effects of schedule shifting.
Slow-wave optimization
employing sensory stimulation to enhance slow waves
normal-sleepers
The first cohort will be used to optimize the the type and duration of sensory stimuli that will optimally enhance slow-waves.
Slow-wave optimization
employing sensory stimulation to enhance slow waves
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Slow-wave optimization
employing sensory stimulation to enhance slow waves
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Left or right-handed subjects may be included.
* Age of ≥18 years and ≤ 75;
* Able to understand and speak English;
* Left or right-handed subjects may be included.
* Age of ≥18 years and ≤ 75;
Exclusion Criteria
* Subjects who have had travel in the last 2 weeks or who intend to travel during the 4 experimental weeks (for at-home subjects) with time zone shifts \>1h;
* The investigator anticipates that the subject will be unable to comply with the protocol.
* Individuals who self-report a current severe or chronic medical condition or sleep disorder that may affect sleep patterns (based on self-report and review with a study clinician).
* Individuals who self-report a history of recurrent seizures or epilepsy or family history of hereditary epilepsy or have a history of medical conditions that could increase the chance of seizures (e.g. stroke, aneurysm, brain surgery, structural brain lesion).
* Subjects who do report not being consistent in their daily use of alcohol, caffeine, or nicotine.
18 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Philips Healthcare
INDUSTRY
University of Wisconsin, Madison
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Guilio Tononi, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Wisconsin, Madison
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
A538900
Identifier Type: OTHER
Identifier Source: secondary_id
SMPH\PSYCHIATRY\PSYCHIATRY
Identifier Type: OTHER
Identifier Source: secondary_id
2015-0337 (H-2009-0052)
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.